Enhanced green fluorescent protein recombinant H5N1 subtype influenza virus and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- MICROBE EPIDEMIC DISEASE INST OF PLA MILITARY MEDICAL ACAD OF SCI
- Publication Date
- 2014-02-05
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a recombinant H5N1 subtype influenza virus and application thereof, in particular to a recombinant H5N1 subtype influenza virus using enhanced green fluorescent protein (EGFP) as a reporter gene and application thereof. Background technique
[0002] The H5N1 subtype influenza virus is a type of influenza A virus that is mainly transmitted in birds. In recent years, reports of H5N1 subtype influenza virus infecting humans have increased year by year. As of August 2012, 608 people have been reported infected in 15 countries and regions around the world, of which 359 people died, with a mortality rate as high as 59%. Infection titer is the basic data required for virus-related basic research and drug and vaccine development. At present, the infectious titer of H5N1 subtype influenza virus is mainly determined by measuring half the tissue culture infectious dose (TCID50) or plaque forming unit (PFU) of the virus, the opera...